3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Programmed cell death 1 (PD-1) inhibitor-related pneumonitis is a rare but clinically serious and potentially life-threatening adverse event. Little is known about its incidence across different tumor types and treatment regimens.

          Related collections

          Author and article information

          Journal
          JAMA Oncol
          JAMA oncology
          American Medical Association (AMA)
          2374-2445
          2374-2437
          Dec 01 2016
          : 2
          : 12
          Affiliations
          [1 ] Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.
          [2 ] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
          [3 ] Department of Medical Oncology and Department of Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
          Article
          2544610
          10.1001/jamaoncol.2016.2453
          27540850

          Comments

          Comment on this article